Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Altamira Therapeutics Ltd (NQ: CYTO )

0.4202 -0.0173 (-3.95%)
Streaming Delayed Price Updated: 2:27 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Altamira Therapeutics Ltd

< Previous 1 2 3 4 5 6 7 8 9 Next >
Altamira Therapeutics Files Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment
From Altamira Therapeutics Ltd
Via GlobeNewswire
Altamira Therapeutics to Report Bentrio Clinical Data, in House Dust Mite and Grass Pollen Allergic Rhinitis, at Feb. 25 AAAAI Annual Meet-ing
Via ACCESSWIRE
Altamira Therapeutics to Present at Two Upcoming RNA Therapeutics Conferences in Q1 2023
Via ACCESSWIRE
Dow Gains Over 100 Points; Eastern Bankshares Shares Drop After Q4 Results
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 1% on Friday. The Dow traded up 0.41% to 34,088.68 while the NASDAQ rose 1.27% to 11,659.16. The S&P 500... 
Via Benzinga
Why Applied UV Shares Are Trading Higher By 46%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers FOXO Technologies Inc. (NYSE: FOXO) shares jumped 109% to $1.07. Akanda Corp. (NASDAQ: AKAN) rose 59% to $0.4459 after jumping 47% on Thursday. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  During Friday, 24 stocks hit new 52-week lows. 
Via Benzinga
US Stocks Higher; Dow Rises 150 Points
U.S. stocks traded higher this morning, with the Dow Jones gaining over 50 points on Friday. Following the market opening Friday, the Dow traded up 0.47% to 34,107.87 while the NASDAQ rose 0.55% to... 
Via Benzinga
Altamira Therapeutics Provides Business Update
From Altamira Therapeutics Ltd
Via GlobeNewswire
Dow Rises 80 Points; Altamira Therapeutics Shares Plunge
U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 80 points on Tuesday. The Dow traded up 0.24% to 33,710.06 while the NASDAQ fell 0.21% to 11,340.24. The S&P 500... 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  During Tuesday, 17 stocks hit new 52-week lows. 
Via Benzinga
Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Baudax Bio, Inc. (NASDAQ: BXRX) shares surged 59.7% to $5.03 after the company announced the outcome of its first interim analysis in a Phase II trial of BX1000 for neuromuscular blockade in... 
Via Benzinga
Dow Drops 100 Points; Verizon Issues Weak Earnings Forecast
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.31% to 33,524.12 while the NASDAQ fell... 
Via Benzinga
Altamira Therapeutics Provides Update on Clinical Trials with Bentrio
From Altamira Therapeutics Ltd
Via GlobeNewswire
Altamira Therapeutics to Present at 2nd Annual mRNA-Based Therapeutics Summit Europe Conference January 24th to 26th
From Altamira Therapeutics Ltd
Via GlobeNewswire
Altamira Therapeutics Provides Year-End 2022 Business Update
From Altamira Therapeutics Ltd
Via GlobeNewswire
Altamira Therapeutics Reaches Midpoint for Enrollment in Clinical Trial with Bentrio in Seasonal Allergic Rhinitis in Australia
Via ACCESSWIRE
Altamira Therapeutics Provides Business Update and First Half 2022 Financial Results
From Altamira Therapeutics Ltd
Via GlobeNewswire
Altamira Therapeutics Announces Launch of Bentrio in Hong Kong by its Partner Nuance Pharma
From Altamira Therapeutics Ltd
Via GlobeNewswire
In Vivo Data Presented at AHA Conference Demonstrates Altamira Therapeutics' SemaPhore mRNA Delivery Platform to Effectively Help Preserve Atherosclerotic Plaque Stability
Via ACCESSWIRE
Altamira Therapeutics to Participate at TIDES Europe Oligonucleotide and Peptide Therapeutics Hybrid Event
From Altamira Therapeutics Ltd
Via GlobeNewswire
Altamira Therapeutics Regains Listing Compliance with NASDAQ Minimum Bid Requirement
From Altamira Therapeutics Ltd
Via GlobeNewswire
Data Published in Peer-Reviewed Journal Demonstrate Protective Effects of Altamira’s Bentrio under Controlled Grass Pollen Exposure
From Altamira Therapeutics Ltd
Via GlobeNewswire
Altamira Therapeutics Announces Reverse Stock Split
From Altamira Therapeutics Ltd
Via GlobeNewswire
Why Tricida Shares Dipped Around 95%; Here Are 73 Biggest Movers From Yesterday
Gainers Applied Genetic Technologies Corporation (NASDAQ: AGTC) climbed 62.4% to close at $0.39. Syncona disclosed that it will acquire Applied Genetic Technologies Corporation. 
Via Benzinga
Dow Jumps 650 Points; Gold Rises Over 1%
U.S. stocks traded higher toward the end of trading, with the Dow Jones jumping around 650 points on Friday. 
Via Benzinga
Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) jumped 89.3% to close at $58.92 on Friday. 
Via Benzinga
Nasdaq Surges 150 Points; Snap Shares Plunge
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 500 points on Friday. 
Via Benzinga
Why Boston Beer Shares Are Trading Higher? Here Are 52 Stocks Moving In Friday's Mid-Day Session
Gainers Altamira Therapeutics Ltd. (NASDAQ: CYTO) surged 67% to $0.5484 after the company announced divestiture of its inner ear development assets. 
Via Benzinga
Why Are Big Tech Stocks Down Today?
Big tech stocks aren't doing so hot on Friday and it looks like traders have Snap's (SNAP) Q3 earnings to blame for the fall. 
Via InvestorPlace
Why Is Altamira Therapeutics (CYTO) Stock Up 70% Today?
Altamira wants to be a leaner, more focused business, and a decision to divest certain assets has CYTO stock traders feeling bullish today. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.